Variant report

Variant	nsv1036756
Chromosome Location	chr13:87098883-87134263
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:2)
LncRNA
region (count:4)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr13:86748899..86749431-chr13:87116065..87116706,2	MCF-7	breast:
2	chr13:86659406..86660238-chr13:87098032..87098996,2	MCF-7	breast:

(count:4 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SLITRK6-13	chr13:87121092-87121529	l_895_chr13:87064439-87121529_brain
2	lnc-SLITRK6-13	chr13:87121092-87121362	NONHSAT034578
3	lnc-SLITRK6-13	chr13:87121092-87121515	NONHSAT034577
4	lnc-SLITRK6-13	chr13:87121092-87121219	NONHSAT034575

No data

Extended variants
information (count: 294 )
Associated
traits (count: 89 )

Variant overlapped rSNPs/rCNVs (count:294 , 50 per page) page: 1 2 3 4 5 6

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs372486753	chr13:87098894-87098895	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs190035381	chr13:87098921-87098922	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs537128709	chr13:87098926-87098927	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs149207973	chr13:87098933-87098934	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs376059210	chr13:87098947-87098948	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs574285899	chr13:87098994-87098995	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs567453558	chr13:87099008-87099009	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs7981296	chr13:87099025-87099026	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs180688759	chr13:87099029-87099030	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs560142614	chr13:87099043-87099044	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs572328473	chr13:87099048-87099049	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs185126759	chr13:87099056-87099057	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs370372767	chr13:87099058-87099059	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs190767314	chr13:87099073-87099074	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs531234690	chr13:87099079-87099080	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs549898379	chr13:87099124-87099125	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs561806559	chr13:87099176-87099177	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs529465483	chr13:87099201-87099202	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs534685908	chr13:87099202-87099203	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs207474157	chr13:87099216-87099217	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs548012026	chr13:87099233-87099234	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs566212884	chr13:87099262-87099263	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs113522322	chr13:87099375-87099376	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs540112519	chr13:87099406-87099407	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs551817952	chr13:87099411-87099412	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs143352525	chr13:87099412-87099413	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs146839871	chr13:87099416-87099417	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs555401285	chr13:87099417-87099418	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs183349901	chr13:87099429-87099430	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs546722512	chr13:87099436-87099437	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs534356962	chr13:87099438-87099439	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs534473064	chr13:87099440-87099441	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs187575897	chr13:87099444-87099445	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs375327689	chr13:87099446-87099447	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs377273296	chr13:87099447-87099448	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs73539172	chr13:87099457-87099458	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs543448871	chr13:87099533-87099534	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs571616031	chr13:87099603-87099604	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs9586760	chr13:87099605-87099606	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs554242191	chr13:87099652-87099653	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs34811153	chr13:87099654-87099655	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs529018181	chr13:87099655-87099656	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs541230199	chr13:87099678-87099679	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs191510085	chr13:87099723-87099724	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs140628171	chr13:87099729-87099730	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs7318294	chr13:87099779-87099780	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs116274768	chr13:87099803-87099804	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs9519627	chr13:87099840-87099841	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs138264890	chr13:87099858-87099859	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs567388482	chr13:87099875-87099876	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:89)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
HIV/AIDS	22032296	CNVD
Prostate cancer	16705090	CNVD
High-proliferative meningiomas	17937814	CNVD
Cancer	20164919	CNVD
Autism	22495311	CNVD
Chordoma	21602918	CNVD
Bladder cancer	21949216	CNVD
Acute myeloid leukemia	16864856	CNVD
Burkitt''s lymphoma	18698080	CNVD
Cancer	21637783	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	21518781	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Ovarian cancer	20844748	CNVD
Colorectal cancer	19359472	CNVD
Intracranial aneurysm	19064780	CNVD
Breast cancer	19287154	CNVD
Acute myeloid leukemia	18379011	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Multiple myeloma	17077331	CNVD
Ependymoma	16718352	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Colorectal cancer	16272173	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	17133270	CNVD
Myoepithelioma	18604193	CNVD
Prostate cancer	18632612	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Developmental delay	21147756	CNVD
Melanoma	18172304	CNVD
Prostate cancer	16573809	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Basal cell lymphoma	17053054	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Metanephric adenoma	20802469	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Gastric cancer	17908304	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Liposarcoma	21253554	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute myeloid leukemia	20729466	CNVD
abnormal development	18461090	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Esophageal cancer	21851588	CNVD
Prostate cancer	21965145	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Cancer	21220470	CNVD
Cancer	21183584	CNVD
Omodysplasia	19481194	CNVD
Breast cancer	22032731	CNVD
Congenital anomalies of the kidney and urinary tract	20467480	CNVD
Cancer	17160897	CNVD
Mantle cell lymphoma	19690137	CNVD
Rhabdomyosarcoma	17210683	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Breast cancer	21364760	CNVD
Myelofibrosis	22110671	CNVD
Gastric adenocarcinoma	19115996	CNVD
Non-small cell lung cancer	16651412	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Melanoma	20877625	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:31 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr13:87097800-87099000	Enhancers	Hela-S3	cervix
2	chr13:87097800-87099200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
3	chr13:87098000-87099000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
4	chr13:87098000-87099000	Enhancers	iPS-15b Cell Line	embryonic stem cell
5	chr13:87098000-87099000	Enhancers	iPS-20b Cell Line	embryonic stem cell
6	chr13:87098000-87099200	Enhancers	HUES6 Cell Line	embryonic stem cell
7	chr13:87098000-87099800	Enhancers	HUES48 Cell Line	embryonic stem cell
8	chr13:87098000-87100000	Enhancers	ES-I3 Cell Line	embryonic stem cell
9	chr13:87098200-87099000	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
10	chr13:87098200-87099000	Enhancers	iPS-18 Cell Line	embryonic stem cell
11	chr13:87098400-87099000	Enhancers	HUES64 Cell Line	embryonic stem cell
12	chr13:87098400-87099400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
13	chr13:87098600-87099000	Enhancers	Cortex derived primary cultured neurospheres	brain
14	chr13:87098800-87099800	Weak transcription	Fetal Lung	lung
15	chr13:87098800-87102800	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
16	chr13:87099800-87100000	Enhancers	Fetal Lung	lung
17	chr13:87105200-87105600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
18	chr13:87116400-87117200	Enhancers	ES-I3 Cell Line	embryonic stem cell
19	chr13:87116800-87117000	Enhancers	HUES64 Cell Line	embryonic stem cell
20	chr13:87117200-87118200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
21	chr13:87117200-87118200	Weak transcription	HUES64 Cell Line	embryonic stem cell
22	chr13:87118200-87118600	Enhancers	HUES48 Cell Line	embryonic stem cell
23	chr13:87118200-87118600	Enhancers	iPS-20b Cell Line	embryonic stem cell
24	chr13:87118200-87118800	Enhancers	HUES64 Cell Line	embryonic stem cell
25	chr13:87118200-87118800	Enhancers	iPS-15b Cell Line	embryonic stem cell
26	chr13:87118400-87118600	Enhancers	ES-I3 Cell Line	embryonic stem cell
27	chr13:87129000-87129200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
28	chr13:87129000-87129200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
29	chr13:87134200-87134800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
30	chr13:87134200-87134800	Enhancers	iPS-18 Cell Line	embryonic stem cell
31	chr13:87134200-87135600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links